BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19898993)

  • 1. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
    Demokan S; Suoglu Y; Gözeler M; Demir D; Dalay N
    Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
    Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
    Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
    McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
    Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
    Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M; Ghosh S; Roy B
    Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
    Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY
    BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
    Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
    Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.
    Gogolewska M; Kabziński J; Majsterek I
    Int J Occup Med Environ Health; 2023 Dec; 36(6):812-824. PubMed ID: 38099560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.
    Jiao L; Doll MA; Hein DW; Bondy ML; Hassan MM; Hixson JE; Abbruzzese JL; Li D
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2379-86. PubMed ID: 18006927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
    Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck.
    Fronhoffs S; Brüning T; Ortiz-Pallardo E; Bröde P; Koch B; Harth V; Sachinidis A; Bolt HM; Herberhold C; Vetter H; Ko Y
    Carcinogenesis; 2001 Sep; 22(9):1405-12. PubMed ID: 11532862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
    Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
    Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.